Susan E. Dubé

Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA.

Women First HealthCare, Inc. is a specialty pharmaceutical company which provides pharmaceutical and self-care products to women and is dedicated to improving the health and well-being of midlife women. The company markets its products in the United States through a number of channels including its sales force, direct-to-consumer marketing programs through internet sites, womenfirst.com and www.aswechange.com and through its As We Change national mail order catalog. It was founded on November 1, 1996 and is headquartered in San Diego, CA.

Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA.

Women First HealthCare, Inc. is a specialty pharmaceutical company which provides pharmaceutical and self-care products to women and is dedicated to improving the health and well-being of midlife women. The company markets its products in the United States through a number of channels including its sales force, direct-to-consumer marketing programs through internet sites, womenfirst.com and www.aswechange.com and through its As We Change national mail order catalog. It was founded on November 1, 1996 and is headquartered in San Diego, CA.

Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA.

Women First HealthCare, Inc. is a specialty pharmaceutical company which provides pharmaceutical and self-care products to women and is dedicated to improving the health and well-being of midlife women. The company markets its products in the United States through a number of channels including its sales force, direct-to-consumer marketing programs through internet sites, womenfirst.com and www.aswechange.com and through its As We Change national mail order catalog. It was founded on November 1, 1996 and is headquartered in San Diego, CA.

Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA.

Women First HealthCare, Inc. is a specialty pharmaceutical company which provides pharmaceutical and self-care products to women and is dedicated to improving the health and well-being of midlife women. The company markets its products in the United States through a number of channels including its sales force, direct-to-consumer marketing programs through internet sites, womenfirst.com and www.aswechange.com and through its As We Change national mail order catalog. It was founded on November 1, 1996 and is headquartered in San Diego, CA.

Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA.

Women First HealthCare, Inc. is a specialty pharmaceutical company which provides pharmaceutical and self-care products to women and is dedicated to improving the health and well-being of midlife women. The company markets its products in the United States through a number of channels including its sales force, direct-to-consumer marketing programs through internet sites, womenfirst.com and www.aswechange.com and through its As We Change national mail order catalog. It was founded on November 1, 1996 and is headquartered in San Diego, CA.

Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA.

Women First HealthCare, Inc. is a specialty pharmaceutical company which provides pharmaceutical and self-care products to women and is dedicated to improving the health and well-being of midlife women. The company markets its products in the United States through a number of channels including its sales force, direct-to-consumer marketing programs through internet sites, womenfirst.com and www.aswechange.com and through its As We Change national mail order catalog. It was founded on November 1, 1996 and is headquartered in San Diego, CA.

Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA.

Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA.

Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA.

Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA.

Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA.

Women First HealthCare, Inc. is a specialty pharmaceutical company which provides pharmaceutical and self-care products to women and is dedicated to improving the health and well-being of midlife women. The company markets its products in the United States through a number of channels including its sales force, direct-to-consumer marketing programs through internet sites, womenfirst.com and www.aswechange.com and through its As We Change national mail order catalog. It was founded on November 1, 1996 and is headquartered in San Diego, CA.

Women First HealthCare, Inc. is a specialty pharmaceutical company which provides pharmaceutical and self-care products to women and is dedicated to improving the health and well-being of midlife women. The company markets its products in the United States through a number of channels including its sales force, direct-to-consumer marketing programs through internet sites, womenfirst.com and www.aswechange.com and through its As We Change national mail order catalog. It was founded on November 1, 1996 and is headquartered in San Diego, CA.

Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA.

Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA.

Women First HealthCare, Inc. is a specialty pharmaceutical company which provides pharmaceutical and self-care products to women and is dedicated to improving the health and well-being of midlife women. The company markets its products in the United States through a number of channels including its sales force, direct-to-consumer marketing programs through internet sites, womenfirst.com and www.aswechange.com and through its As We Change national mail order catalog. It was founded on November 1, 1996 and is headquartered in San Diego, CA.

Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA.

Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA.

Women First HealthCare, Inc. is a specialty pharmaceutical company which provides pharmaceutical and self-care products to women and is dedicated to improving the health and well-being of midlife women. The company markets its products in the United States through a number of channels including its sales force, direct-to-consumer marketing programs through internet sites, womenfirst.com and www.aswechange.com and through its As We Change national mail order catalog. It was founded on November 1, 1996 and is headquartered in San Diego, CA.

Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA.

Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA.

Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA.

Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA.

Imagyn Medical Technologies, Inc. develops and manufactures equipment for general surgery. The firm markets its products to hospitals and other health care providers through direct sales, distributors and on the internet. The company is headquartered in Irvine, CA.

Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA.